Risk of Cataract in Intermediate Uveitis

Area of Science:

• Ophthalmology
• Immunology
• Clinical Medicine

Background:

• Intermediate uveitis is an intraocular inflammatory condition.
• Cataract is a known complication of ocular inflammation and corticosteroid use.

Purpose of the Study:

• To determine the incidence of cataract in patients with intermediate uveitis.
• To identify predictive factors for cataract development in this patient population.

Main Methods:

• Retrospective cohort study of 2,190 eyes from 1,302 patients with intermediate uveitis.
• Data collected from the Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study.
• Survival analysis used to assess visually defined cataract development.

Main Results:

• Cumulative cataract incidence reached 36.6% by 10 years.
• Increased cataract risk associated with concurrent anterior uveitis with posterior synechiae (HR=2.68) and epiretinal membrane (HR=1.54).
• Higher corticosteroid doses (topical ≥2 times/day or ≥4 periocular injections) significantly increased cataract risk; low doses did not.

Conclusions:

• The incidence of clinically significant cataract in intermediate uveitis is moderate.
• Risk factors include markers of disease severity and high-dose corticosteroid therapy.
• Reducing high-dose corticosteroid use may mitigate cataract risk.